Purdue Pharma to use Sackler cash, public trusts to settle opioid litigation

A bankruptcy plan was filed by Purdue Pharma LP which aims to resolve thousands of opioid lawsuits by restructuring the OxyContin maker into an entity, which would then steer profits to plaintiffs. The move would also require the company’s Sackler family owners to contribute nearly $4.3 billion to the settlement. The plan is intended to act as the company’s roadmap out of bankruptcy.